Nova Mentis Life Science Corp. announce that Dr. Aylia Mohammadi has joined the Company's Board of Directors. Dr. Aylia Mohammadi is an experienced scientist with research expertise in both basic science and clinical translation. As President and Chief Scientific Officer of Nova Mentis Biotech Corp., Dr. Aylia Mohammadi will spearhead and oversee all research and development initiatives driven by the company, focused on investigating the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes.